Table 2. Results on Spatiotemporal Parameters During Different Gait Tasks.
| Without Sensory Alterations | Alterations of Vision | Head Rotations | Tandem Walking | Dual Task | |
|---|---|---|---|---|---|
| Gait velocity | |||||
| pwBPPV vs control | ↘ P < 0.0001; SMD = −0.75a |
↘ | ↘ | ↘ | ↘ |
| Treatment effect | ↗ P = 0.001; SMD = −0.51a |
/ | = | = older pwBPPV ↗ younger pwBPPV | / |
| Cadence | |||||
| pwBPPV vs control | ↘ P = 0.02; SMD = −0.48a |
/ | = | / | |
| Treatment effect | ↗ | / | / | / | |
| Step/stride length | |||||
| pwBPPV vs control | ↘ P = 0.005; SMD = −0.54a |
/ | ↘ | / | |
| Treatment effect | ↗ P = 0.001; SMD = −0.51a |
/ | / | / | |
| Sway velocity | |||||
| pwBPPV vs control | / | / | / | = | / |
| Treatment effect | / | / | / | = P = 0.22; SMD = 0.20a |
/ |
Abbreviations: pwBPPV, people with benign paroxysmal positional vertigo; SMD, standardized mean difference; ↘, significantly decreased in people with benign paroxysmal positional vertigo; ↗, significantly improved after treatment with particle repositioning maneuvers; =, no significant difference; /, no literature available.
aP values and SMD of meta-analysis.